Enzon Divests Specialty Business to Sigma-tau
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 16 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1272 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Enzon Pharmaceuticals sold its specialty pharma unit to Italian drug maker, Sigma-tau Group for a total of US$327M in cash plus royalties...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS